Skip to main content

Table 1 Standard treatments with curettage for GCTBa in 24 institutions

From: Clinical outcome of primary giant cell tumor of bone after curettage with or without perioperative denosumab in Japan: from a questionnaire for JCOG 1610 study

Treatments No. of institutions (%)
Local adjuvants
 High-speed burr 22 (92%)
 Ethanol 8 (33%)
 Liquid nitrogen 6 (25%)
 Phenol 3 (13%)
Reconstruction after curettage
 Autologous bone graft 18 (75%)
 PMMAb 17 (71%)
 β-TCPc 11 (46%)
 Hydroxyapatite 10 (42%)
 Allogeneic bone graft 2 (8%)
  1. aGCTB giant cell tumor of bone
  2. bPMMA, polymethyl methacrylate
  3. cβ-TCP, β tricalcium phosphate; some of the replies by responded institutions are overlapped